Skip to content
10-Q

Quarterly Report

Immunocore Holdings plc IMCR

0001671927-25-000018

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 50.53M sh
Shares Diluted Q3 2025 · Sep 30, 2025 50.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 50.26M sh
Shares Diluted Q3 2025 · Sep 30, 2024 52.81M sh
Shares Diluted Q3 2025 · Sep 30, 2024 49.97M sh
Capex Q3 2025 · Sep 30, 2025 $1.46M
Capex Q3 2025 · Sep 30, 2024 $1.59M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $21.94M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $40.01M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $498.41M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $455.73M
Stockholders Equity Q3 2025 · Sep 30, 2025 $396.56M
Stockholders Equity Q3 2025 · Jun 30, 2025 $388.48M
Stockholders Equity Q3 2025 · Mar 31, 2025 $378.48M
Stockholders Equity Q3 2025 · Dec 31, 2024 $360.72M
Stockholders Equity Q3 2025 · Sep 30, 2024 $377.83M
Stockholders Equity Q3 2025 · Jun 30, 2024 $359.14M
Stockholders Equity Q3 2025 · Mar 31, 2024 $359.53M
Stockholders Equity Q3 2025 · Dec 31, 2023 $368.84M
Current Liabilities Q3 2025 · Sep 30, 2025 $170.35M
Current Liabilities Q3 2025 · Dec 31, 2024 $212.18M
Total Liabilities Q3 2025 · Sep 30, 2025 $705.94M
Total Liabilities Q3 2025 · Dec 31, 2024 $648.79M
Current Assets Q3 2025 · Sep 30, 2025 $1.02B
Current Assets Q3 2025 · Dec 31, 2024 $929.86M
Total Assets Q3 2025 · Sep 30, 2025 $1.1B
Total Assets Q3 2025 · Dec 31, 2024 $1.01B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2024 $0.17
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.55
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 −$0.11
Eps Basic Q3 2025 · Sep 30, 2024 $0.17
Eps Basic Q3 2025 · Sep 30, 2024 −$0.55
Sga Expense Q3 2025 · Sep 30, 2025 $39.78M
Sga Expense Q3 2025 · Sep 30, 2025 $122.77M
Sga Expense Q3 2025 · Sep 30, 2024 $35.53M
Sga Expense Q3 2025 · Sep 30, 2024 $113.46M
Rd Expense Q3 2025 · Sep 30, 2025 $70.57M
Rd Expense Q3 2025 · Sep 30, 2025 $196.05M
Rd Expense Q3 2025 · Sep 30, 2024 $52.77M
Rd Expense Q3 2025 · Sep 30, 2024 $161.3M
Net Income Q3 2025 · Sep 30, 2025 −$177K
Net Income Q3 2025 · Sep 30, 2025 −$5.45M
Net Income Q3 2025 · Jun 30, 2025 −$10.3M
Net Income Q3 2025 · Mar 31, 2025 $5.02M
Net Income Q3 2025 · Sep 30, 2024 $8.74M
Net Income Q3 2025 · Sep 30, 2024 −$27.32M
Net Income Q3 2025 · Jun 30, 2024 −$11.62M
Net Income Q3 2025 · Mar 31, 2024 −$24.44M
Operating Income Q3 2025 · Sep 30, 2025 −$7.17M
Operating Income Q3 2025 · Sep 30, 2025 −$25.66M
Operating Income Q3 2025 · Sep 30, 2024 −$8.5M
Operating Income Q3 2025 · Sep 30, 2024 −$51.01M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $513K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.38M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $448K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.4M
Revenue Q3 2025 · Sep 30, 2025 $103.69M
Revenue Q3 2025 · Sep 30, 2025 $295.54M
Revenue Q3 2025 · Sep 30, 2024 $80.25M
Revenue Q3 2025 · Sep 30, 2024 $226.15M